JP2008503447A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008503447A5 JP2008503447A5 JP2007513845A JP2007513845A JP2008503447A5 JP 2008503447 A5 JP2008503447 A5 JP 2008503447A5 JP 2007513845 A JP2007513845 A JP 2007513845A JP 2007513845 A JP2007513845 A JP 2007513845A JP 2008503447 A5 JP2008503447 A5 JP 2008503447A5
- Authority
- JP
- Japan
- Prior art keywords
- phenyl
- disease
- thiazol
- acetic acid
- fluoro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0412198A GB0412198D0 (en) | 2004-05-29 | 2004-05-29 | Medicinal use of receptor ligands |
| GB0414194A GB0414194D0 (en) | 2004-06-24 | 2004-06-24 | Medicinal use of receptor ligands |
| GB0424016A GB0424016D0 (en) | 2004-10-29 | 2004-10-29 | Medicinal use of receptor ligands |
| PCT/EP2005/005882 WO2005116001A1 (en) | 2004-05-29 | 2005-05-30 | Substituted thiazoleacetic as crth2 ligands |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008503447A JP2008503447A (ja) | 2008-02-07 |
| JP2008503447A5 true JP2008503447A5 (enExample) | 2008-07-24 |
Family
ID=34968996
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007513845A Withdrawn JP2008503447A (ja) | 2004-05-29 | 2005-05-30 | Ｃｒｔｈ２リガンドとしての置換チアゾール酢酸 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20080119456A1 (enExample) |
| EP (1) | EP1758874A1 (enExample) |
| JP (1) | JP2008503447A (enExample) |
| KR (1) | KR20070044404A (enExample) |
| AU (1) | AU2005247610A1 (enExample) |
| BR (1) | BRPI0511671A (enExample) |
| CA (1) | CA2568742A1 (enExample) |
| CR (1) | CR8837A (enExample) |
| EA (1) | EA200602288A1 (enExample) |
| IL (1) | IL179693A0 (enExample) |
| MX (1) | MXPA06013924A (enExample) |
| NO (1) | NO20066049L (enExample) |
| WO (1) | WO2005116001A1 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0427381D0 (en) * | 2004-12-14 | 2005-01-19 | Novartis Ag | Organic compounds |
| UY30892A1 (es) * | 2007-02-07 | 2008-09-02 | Smithkline Beckman Corp | Inhibidores de la actividad akt |
| US8268872B2 (en) | 2008-02-22 | 2012-09-18 | Radius Health, Inc. | Selective androgen receptor modulators |
| BRPI0907844B8 (pt) | 2008-02-22 | 2021-05-25 | Radius Health Inc | compostos e método para modular um receptor de andrógeno, processos de preparação e composição farmacêutica dos mesmos e seus usos |
| JP5535931B2 (ja) | 2008-10-27 | 2014-07-02 | 武田薬品工業株式会社 | 二環性化合物 |
| WO2010088331A1 (en) * | 2009-01-30 | 2010-08-05 | Glaxosmithkline Llc | Crystalline n-{(1-s)-2-amino-1-[(3-fluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1h-pyrazol-5-yl)-2-thiophenecarboxamide hydrochloride |
| EP2516416A1 (en) | 2009-12-23 | 2012-10-31 | Ironwood Pharmaceuticals, Inc. | Crth2 modulators |
| AU2011212813B2 (en) | 2010-02-04 | 2014-10-23 | Radius Health, Inc. | Selective androgen receptor modulators |
| SI2568806T1 (sl) | 2010-05-12 | 2016-09-30 | Radius Health, Inc. | Režimi zdravljenja |
| US8642632B2 (en) | 2010-07-02 | 2014-02-04 | Radius Health, Inc. | Selective androgen receptor modulators |
| EP2621901B1 (en) | 2010-09-28 | 2015-07-29 | Radius Health, Inc | Selective androgen receptor modulators |
| EP2457900A1 (en) | 2010-11-25 | 2012-05-30 | Almirall, S.A. | New pyrazole derivatives having CRTh2 antagonistic behaviour |
| CA2859284A1 (en) | 2011-12-16 | 2013-06-20 | Atopix Therapeutics Limited | Combination of a crth2 antagonist and a proton pump inhibitor for the treatment of eosinophilic esophagitis |
| RS63311B1 (sr) | 2016-06-22 | 2022-07-29 | Ellipses Pharma Ltd | Ar+ metode lečenja raka dojke |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ID24390A (id) * | 1997-07-10 | 2000-07-13 | Janssen Pharmaceutica Nv | Turunan-turunan 6-azaurasil penghambat il-5 |
| HUP0004238A3 (en) * | 1997-11-28 | 2001-07-30 | Lg Chemical Ltd | Imidazole derivatives having an inhibitory activity for farnesyl transferase, process for preparation thereof and pharmaceutical compositions containing them |
| EP0987265A1 (en) * | 1998-09-18 | 2000-03-22 | Janssen Pharmaceutica N.V. | Interleukin-5 inhibiting 6-azauracil derivatives |
| EE200200057A (et) * | 1999-08-06 | 2003-04-15 | Janssen Pharmaceutica N.V. | Kasvutegurit IL-5 pärssiv asauratsiilderivaat, selle saamine ja kasutamine ravimi valmistamiseks ning seda sisaldav farmatseutiline kompositsioon |
| US7276526B2 (en) * | 2001-07-13 | 2007-10-02 | Bristol-Myers Squibb Pharma Company | Substituted thiazoles and oxazoles as corticotropin releasing hormone ligands |
| TW200307542A (en) * | 2002-05-30 | 2003-12-16 | Astrazeneca Ab | Novel compounds |
-
2005
- 2005-05-30 BR BRPI0511671-6A patent/BRPI0511671A/pt not_active IP Right Cessation
- 2005-05-30 EP EP05748037A patent/EP1758874A1/en not_active Withdrawn
- 2005-05-30 EA EA200602288A patent/EA200602288A1/ru unknown
- 2005-05-30 MX MXPA06013924A patent/MXPA06013924A/es not_active Application Discontinuation
- 2005-05-30 KR KR1020067027509A patent/KR20070044404A/ko not_active Withdrawn
- 2005-05-30 CA CA002568742A patent/CA2568742A1/en not_active Abandoned
- 2005-05-30 JP JP2007513845A patent/JP2008503447A/ja not_active Withdrawn
- 2005-05-30 WO PCT/EP2005/005882 patent/WO2005116001A1/en not_active Ceased
- 2005-05-30 AU AU2005247610A patent/AU2005247610A1/en not_active Abandoned
- 2005-05-30 US US11/597,839 patent/US20080119456A1/en not_active Abandoned
-
2006
- 2006-11-29 IL IL179693A patent/IL179693A0/en unknown
- 2006-12-22 CR CR8837A patent/CR8837A/es unknown
- 2006-12-28 NO NO20066049A patent/NO20066049L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008500991A5 (enExample) | ||
| JP2008503447A5 (enExample) | ||
| NZ597381A (en) | Thiazolidinedione analogues for the treatment of diabetes and inflammatory diseases | |
| ES2549087T3 (es) | Derivados de aminodihidrotiazina como inhibidores de BACE para el tratamiento de la enfermedad de Alzheimer | |
| JP2021504443A5 (enExample) | ||
| JP2009517417A5 (enExample) | ||
| RU2315041C2 (ru) | Производные 2,6-хинолинила и 2,6-нафтила, фармацевтические композиции на их основе, их применение в качестве ингибиторов vla-4 и промежуточные соединения | |
| WO2007126043A1 (ja) | チアゾール環を含むカルボン酸誘導体の医薬用途 | |
| HRP20161177T1 (hr) | Modulator glukagonskog receptora | |
| JP2008500991A (ja) | 医学的使用のためのｃｒｔｈ２レセプターリガンド | |
| JP2008513515A5 (enExample) | ||
| JP2018519323A5 (enExample) | ||
| CA2587800A1 (en) | Fused aminopiperidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes | |
| JP2007519695A5 (enExample) | ||
| JP2007520471A5 (enExample) | ||
| JP2011513305A5 (enExample) | ||
| JP2015502387A5 (enExample) | ||
| JP2010513434A5 (enExample) | ||
| NZ566788A (en) | Biaryl substituted heterocycle inhibitors of LTA4H for treating inflammation | |
| JP2009539848A5 (enExample) | ||
| JP2012255002A5 (enExample) | ||
| JP2013531055A5 (enExample) | ||
| JP2013541596A5 (enExample) | ||
| JP2016529264A5 (enExample) | ||
| JP2010502576A5 (enExample) |